 CBL-B functions as a negative regulator of T-cell activation.CBL-B expression in T cells causes ligand-induced T cell receptor down-modulation, controlling the activation degree of T cells during antigen presentation.Mutation of the CBLB gene has been associated with autoimmune conditions such as type 1 diabetes.